| Filed On | Filing |
|---|---|
| 24 Apr 2026 |
8-K/A: Financial Statements and Exhibits
On April 20, 2026 (the “Distribution Date”), AnaptysBio, Inc. (the “Company” or “AnaptysBio”) completed the separation of its biopharma operations by means of a spin-off (the “Spin-Off”) into a new, independent public company, First Trac... |
Loading...
